Cargando…
Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia
Several SARS-CoV-2 variants of concern (VOC) and interest (VOI) co-circulate in Colombia, and determining the neutralizing antibody (nAb) responses is useful to improve the efficacy of COVID-19 vaccination programs. Thus, nAb responses against SARS-CoV-2 isolates from the lineages B.1.111, P.1 (Gamm...
Autores principales: | Álvarez-Díaz, Diego A., Muñoz, Ana Luisa, Herrera-Sepúlveda, María T., Tavera-Rodríguez, Pilar, Laiton-Donato, Katherine, Franco-Muñoz, Carlos, Ruiz-Moreno, Héctor Alejandro, Galindo, Marisol, Catama, Jenssy D., Bermudez-Forero, Andrea, Mercado-Reyes, Marcela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786731/ https://www.ncbi.nlm.nih.gov/pubmed/36560554 http://dx.doi.org/10.3390/vaccines10122144 |
Ejemplares similares
-
Low Neutralizing Antibody Titers against the Mu Variant of SARS-CoV-2 in 31 BNT162b2 Vaccinated Individuals in Colombia
por: Álvarez-Díaz, Diego A., et al.
Publicado: (2022) -
Clinical outcomes associated with Mu variant infection during the third epidemic peak of COVID-19 in Colombia
por: Álvarez-Díaz, Diego A., et al.
Publicado: (2022) -
Seroprevalence of SARS-CoV-2 Antibodies in Children and Adolescents:
Results From a Population-Based Survey in 10 Colombian Cities
por: Mercado-Reyes, Marcela María, et al.
Publicado: (2022) -
Comparison of Anti-SARS-CoV-2 IgG Antibody Responses Generated by the Administration of Ad26.COV2.S, AZD1222, BNT162b2, or CoronaVac: Longitudinal Prospective Cohort Study in the Colombian Population, 2021/2022
por: Malagón-Rojas, Jeadran, et al.
Publicado: (2022) -
Monkeypox virus genome sequence from an imported human case in Colombia
por: Laiton-Donato, Katherine, et al.
Publicado: (2022)